Erythropoietin/erythropoietin-receptor system is involved in angiogenesis in human hepatocellular carcinoma

Histopathology

Volumn 50, Issue 5, 2007, Pages 591-596

  Ribatti, D ^a,b   Marzullo, A ^a   Gentile, A ^a   Longo, V ^a   Nico, B ^a   Vacca, A ^a   Dammacco, F ^a  

^a UNIVERSITY OF BARI MEDICAL SCHOOL   (Italy)

^b POLICLINICO   (Italy)

Author keywords

Angiogenesis; Erythropoietin; Erythropoietin receptor; Hepatocellular carcinoma

Indexed keywords

ERYTHROPOIETIN; ERYTHROPOIETIN RECEPTOR;

ADULT; AGED; ANGIOGENESIS; ARTICLE; CANCER GRADING; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; LIVER RESECTION; MALE; MICROVASCULATURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; TUMOR VASCULARIZATION;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; DISEASE PROGRESSION; ERYTHROPOIETIN; FEMALE; HEPATECTOMY; HUMANS; IMMUNOENZYME TECHNIQUES; LIVER NEOPLASMS; MALE; MICROCIRCULATION; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; RECEPTORS, ERYTHROPOIETIN; TUMOR MARKERS, BIOLOGICAL;

EID: 33947696124     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2007.02654.x     Document Type: Article

References (30)

1. Schuster SJ, Koury ST, Bohler M, Salceda S, Card J. Cellular sites of extrarenal and renal erythropoietin production in anaemic rats. Br. J. Haematol. 1992; 81; 153-159.
2. Lacombe C, Mateux P. Biology of erythropoietin. Haematologica 1998; 83; 724-732.
3. Ribatti D, Vacca A, Roccaro AM, Crivellato E, Presta M. Erythropoietin as an angiogenic factor. Eur. J. Clin. Invest. 2003; 33; 891-896.
4. Anagnostou A, Liu Z, Steiner M et al. Erythropoietin receptor mRNA expression in human endothelial cells. Proc. Natl Acad. Sci. USA 1994; 91; 3974-3978.
5. Anagnostou A, Lee ES, Kessimian N, Levinson R, Steiner M. Erythropoietin has a mitogenic and positive chemotactic effect on endothelial cells. Proc. Natl Acad. Sci. USA 1990; 87; 5878-5982.
6. Ashley RA, Dubuque SH, Dvorak B, Woodward SS, Williams SK, Kling PJ. Erythropoietin stimulates vasculogenesis in neonatal rat mesenteric microvascular endothelial cells. Pediatr. Res. 2002; 51; 472-478.
7. Carlini RG, Reyes AA, Rothstein A. Recombinant human erythropoietin stimulates angiogenesis in vitro. Kidney Int. 1995; 47; 740-748.
8. Ribatti D, Presta M, Vacca A et al. Human erythropoietin induces a pro-angiogenic phenotype in cultured endothelial cells and stimulates neovascularization in vivo. Blood 1999; 93; 2627-2636.
9. Jaquet K, Krause K, Tawakol-Khodai M, Geidel S, Kuch KM. Eryhropoietin and VEGF exhibit angiogenic potential. Microvasc. Res. 2002; 64; 326-333.
10. Semela D, Dufour JF. Angiogenesis and hepatocellular carcinoma. J. Hepatol. 2004; 41; 864-880.
11. Zacharoulis D, Hatzitheofilou C, Athanasiou E, Zacharoulis S. Antiangiogenic strategies in hepatocellular carcinoma: current status. Expert Rev. Anticancer Ther. 2005; 5; 645-656.
12. Sakamoto M, Ino Y, Fujii T, Hirohashi S. Phenotype changes in tumor vessels associated with the progression of hepatocellular carcinoma. Jpn J. Clin. Oncol. 1993; 23; 98-104.
13. Horak ER, Leek R, Kenk N et al. Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer. Lancet 1992; 340; 1120-1124.
14. Vacca A, Ribatti D, Roncali L et al. Melanocyte tumor progression is associated with changes in angiogenesis and expression of the 67-kilodalton laminin receptor. Cancer 1993; 72; 455-461.
15. Ribatti D, Nico B, Vacca A et al. Do mast cells help to induce angiogenesis in B-cell non Hodgkin's lymphoma? Br. J. Cancer 1998; 77; 1900-1906.
16. Kayser K, Gabius HJ. Analysis of expression of erythropoietin-binding sites in human lung carcinoma by the biotinylated ligand. Zentrabl. Pathol. 1992; 138; 266-270.
17. Westenfelder C, Baranowski RL. Erythropoietin stimulates proliferation of human renal carcinoma cells. Kidney Int. 2000; 58; 647-657.
18. Yasuda Y, Musha T, Tanaka H et al. Inhibition of erythropoietin signalling destroys xenografts of ovarian and uterine cancers in nude mice. Br. J. Cancer 2001; 84; 836-843.
19. Yasuda Y, Fujita Y, Masuda S et al. Erythropoietin is involved in growth and angiogenesis in malignant tumors of female reproductive organs. Carcinogenesis 2002; 23; 1797-1805.
20. Acs G, Zhang PJ, McGrath CM et al. Hypoxia-inducible erythropoietin signaling in squamous dysplasia and squamous cell carcinoma of the uterine cervix and its potential role in cervical carcinogenesis and tumor progression. Am. J. Pathol. 2003; 162; 1789-1806.
21. Batra S, Perelman N, Luck LR, Shimada H, Malik P. Pediatric tumor cells express erythropoietin and a functional erythropoietin receptor that promotes angiogenesis and tumor cell survival. Lab. Invest. 2003; 83; 1477-1487.
22. Hengartner MO, Horvitz HR. C. elegans cell survival gene ced-9 encodes a functional homolog of the mammalian proto-oncogene bcl-2. Cell 1994; 76; 665-676.
23. Acs G, Zhang PJ, Rebbeck TR, Acs P, Verna A. Immunohistochemical expression of erythropoietin and erythropoietin receptor in breast carcinoma. Cancer 2002; 95; 969-981.
24. Arcasoy MO, Amin K, Karayal AF et al. Functional significance of erythropoietin receptor expression in breast cancer. Lab. Invest. 2002; 82; 911-918.
25. Dillard DG, Venkatraman G, Cohen C, Delgaudio J, Gal AA, Mattox DE. Immunolocalization of erythropoietin and erythropoietin receptor in vestibular schwannoma. Acta Otolaryngol. 2001; 121; 149-152.
26. Yasuda Y, Fujita Y, Matsuo T et al. Erythropoietin regulates tumour growth of human malignancies. Carcinogenesis 2003; 24; 1021-1029.
27. Okabe T, Urabe A, Kato T, Chiba S, Takaku F. Production of erythropoietin-like activity by human renal and hepatic carcinoma in cell culture. Cancer 1985; 55; 1918-1923.
28. Matsuyama M, Yamazaki O, Horii K et al. Erythrocytosis caused by an erythropoietin-producing hepatocellular carcinoma. J. Surg. Oncol. 2000; 75; 197-202.
29. Sugimachi K, Tanaka S, Taguchi K et al. Angiopoietin switching regulates angiogenesis and progression of human hepatocellular carcinoma. J. Clin. Pathol. 2003; 56; 854-860.
30. Nakamatsu K, Nishimura Y, Suzuki M, Kanamori S, Maenishi O, Yasuda Y. Erythropoietin/erythropoietin-receptor system as an angiogenic factor in chemically induced hepatic tumors. Int. J. Clin. Oncol. 2004; 9; 184-188.